NetworkNewsBreaks – Cannabis Global, Inc. (MCTC)
Post# of 112
Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced that it has completed product development and has begun distribution of its unique tetrahydrocannabivarin (“THC-V”) coffee and tea products to product beta testers. According to the update, the company has integrated three internally developed technologies into the unique manufacturing process for the industry’s first THC-V beverages. Pending full release of the products, Cannabis Global has implemented a 30-Day beta testing period, during which production for general release will continue. “Our unique infusion and production technologies provide Cannabis Global with a product purity advantage as well as a clear path to low cost leadership,” Cannabis Global CEO Arman Tabatabaei said in the news release. “The THC-V cannabinoids are synthesized and entirely free of impurities. While there were some upfront technology development and intellectual property protection costs, we expect our ongoing variable production costs to be less than half of any potential competitor. Via our technologies, we turn one of the cannabis industry’s most expensive items – pure THC-V cannabinoids – into a cost-effective solution that sets a new standard for product purity in the cannabinoid-based products marketplace.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer